Quarterly report pursuant to Section 13 or 15(d)

10. SEGMENTS (Details)

v3.19.2
10. SEGMENTS (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Revenues $ 6,560,942   $ 4,656,550   $ 10,089,531 $ 8,698,556  
Cost of product revenue 10,491,236   9,645,662   19,896,415 21,888,410  
Loss from operations (11,338,674)   (13,417,381)   (24,547,090) (29,949,884)  
Interest and other (expense) income, net (1,873,198)   (1,330,450)   (3,297,663) (2,620,089)  
Gain on transfer of plasma center assets 0   0   11,527,421 0  
Loss on extinguishment of debt 0   0   (9,962,495) 0  
Net (loss) income (13,211,872) $ (13,067,955) (14,747,831) $ (17,822,142) (26,279,827) (32,569,973)  
Purchase of property and equipment         245,675 1,046,375  
Depreciation and amortization 806,093   845,899   1,611,422 1,675,439  
Total assets 143,274,120   117,751,992   143,274,120 117,751,992 $ 88,876,521
ADMA BioManufacturing              
Revenues 4,002,445   2,144,724   5,346,428 3,810,967  
Cost of product revenue 8,170,381   7,965,681   16,110,727 18,663,323  
Loss from operations (8,671,783)   (9,918,243)   (19,292,591) (22,642,709)  
Interest and other (expense) income, net (246,603)   (237,161)   (416,216) (477,214)  
Gain on transfer of plasma center assets         0    
Loss on extinguishment of debt         0    
Net (loss) income (8,918,386)   (10,155,404)   (19,708,807) (23,119,923)  
Purchase of property and equipment         224,440 591,665  
Depreciation and amortization 688,848   639,300   1,376,240 1,271,131  
Total assets 67,236,416   54,297,915   67,236,416 54,297,915  
Plasma Collection Centers              
Revenues 2,522,788   2,476,117   4,671,686 4,816,172  
Cost of product revenue 2,320,855   1,679,981   3,785,688 3,225,087  
Loss from operations (392,181)   (941,993)   (362,601) (1,980,817)  
Interest and other (expense) income, net (59)   (436)   13,560 (871)  
Gain on transfer of plasma center assets         11,527,421    
Loss on extinguishment of debt         0    
Net (loss) income (392,240)   (942,429)   11,178,380 (1,981,688)  
Purchase of property and equipment         21,235 454,710  
Depreciation and amortization 113,958   200,598   228,199 389,512  
Total assets 3,835,999   5,438,645   3,835,999 5,438,645  
Corporate              
Revenues 35,709   35,709   71,417 71,417  
Cost of product revenue 0   0   0 0  
Loss from operations (2,274,710)   (2,557,145)   (4,891,898) (5,326,358)  
Interest and other (expense) income, net (1,626,536)   (1,092,853)   (2,895,007) (2,142,004)  
Gain on transfer of plasma center assets         0    
Loss on extinguishment of debt         (9,962,495)    
Net (loss) income (3,901,246)   (3,649,998)   (17,749,400) (7,468,362)  
Purchase of property and equipment         0 0  
Depreciation and amortization 3,287   6,001   6,983 14,796  
Total assets $ 72,201,705   $ 58,015,432   $ 72,201,705 $ 58,015,432